COMPANY PROFILE

Gleamer

Explore full profile

Providing imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications

Saint-Mandé, FranceFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2023

Revenue $10–50M Latest reported FY

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Gleamer

GLEAMER is a French company founded in 2017 by Christian Allouche and Alexis Ducarouge. The company develops and markets artificial intelligence-powered software for medical imaging, specifically for radiology.

Read full description

The company's main product is BoneView, a software that uses AI to detect fractures in X-ray images. BoneView is designed to be used by radiologists and emergency physicians to help them make more accurate and efficient diagnoses. The software is CE-marked and has received FDA clearance in the United States.

In addition to BoneView, GLEAMER also offers ChestView, a software that helps detect pulmonary pathologies in chest X-rays.

GLEAMER's business model is based on a subscription fee for its software. The company targets hospitals, clinics, and teleradiology companies as its primary customers.

Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2017
Headquarters: Saint-Mandé, France
Employees: 125
Open positions: 3
Dealroom signal: 83.0/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, X-Ray, Radiology, Medical Imaging, Core AI
Technology: Artificial Intelligence, Deep Tech, Machine Learning
Business model: SaaS
Client focus: b2b
Investment activity: 2 companies, latest Mar 2025
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Mar 2026	$230M	—	RadNet	↗
GRANT✓Other financing	Dec 2024	$5M	—	French Government	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Gleamer website traffic

Latest recorded traffic for Gleamer is 10K monthly website visits, down 23.1% over the last three months. Gleamer's team grew 1.6% over the past year.

Latest monthly visits10K 3-month web change-23.1% 1-year team growth+1.6%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Sales Manager5, Avenue du Général de Gaulle, Saint-Mandé, Nogent-sur-Marne, Val-de-Marne, Ile-de-France, Metropolitan France, 94160, France · Sales · Feb 24, 2026 Deployment & Support EngineerParis, Île-de-France, France · Project Management · Feb 24, 2026

2 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ARArtiQHas developed AI-based software to help doctors save time and improve interpretation of lung function tests and diagnosis of lung diseases	Leuven, Belgium	Acquired	18	$1.1M	$4.5M
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
INinHEARTAI-enabled digital twin of the heart	Pessac, France	Operational
RARadioboticsAutomating routine tasks, alleviating the urgent need for specialized radiologists, whilst improving diagnostic quality	Copenhagen, Denmark	Acquired
CICIBILTECHProvides a prediction of kidney allograft survival, enabling clinicians to anticipate patient health outcomes, improving medical decisions through personalized treatments	Paris, France	Operational
QUQuibimProducer of whole body radiological image analysis based on Artificial Intelligence	Valencia, Spain	Operational
AZAZmedThe first French company to commercialize an AI-powered radiology software	Paris, France	Operational
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational